Patricia Murphy Selected Research

Patricia Murphy Research Topics

Disease

6	Drug Resistant Epilepsy 12/2006 - 08/2003
3	Chronic Disease (Chronic Diseases) 09/2012 - 12/2011
2	Neoplasms (Cancer) 01/2021 - 11/2012
2	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2019 - 11/2017
2	Acquired Immunodeficiency Syndrome (AIDS) 05/2015 - 09/2012
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2006 - 02/2002
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2006 - 03/2005
2	Seizures (Absence Seizure) 08/2003 - 03/2003
1	Cataract (Cataracts) 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Sleepiness 11/2017
1	Mania (Manias) 05/2013
1	Treatment-Resistant Depressive Disorder 05/2013
1	Bipolar Disorder (Manic Depressive Psychosis) 05/2013
1	Brain Neoplasms (Brain Tumor) 11/2012
1	Medulloblastoma 11/2012
1	Hemorrhagic Cystitis 11/2012
1	Typical Teratoid Rhabdoid Tumor 11/2012
1	Primitive Neuroectodermal Tumors (PNET) 11/2012
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2011
1	Uterine Cervical Dysplasia 07/2011
1	Squamous Intraepithelial Lesions 07/2011
1	Infections 04/2011
1	Ischemia 10/2006
1	Acidosis 10/2006
1	Cardiotoxicity 07/2006
1	Heart Arrest (Cardiac Arrest) 07/2006
1	Epilepsy (Aura) 11/2005
1	Breast Neoplasms (Breast Cancer) 05/2005
1	Ovarian Epithelial Carcinoma 02/2005
1	Lennox Gastaut Syndrome 08/2003
1	Neuroinflammatory Diseases 02/2002
1	Wounds and Injuries (Trauma) 02/2002
1	Hypercholesterolemia 01/2002
1	Coronary Disease (Coronary Heart Disease) 01/2002

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2018 - 11/2005
3	Anticonvulsants (Antiepileptic Drugs)IBA 11/2005 - 08/2003
2	lemborexantIBA 12/2019 - 11/2017
2	Orexin Receptor AntagonistsIBA 12/2019 - 11/2017
2	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 10/2006 - 07/2006
1	Zolpidem (Ambien)FDA LinkGeneric 12/2019
1	ivacaftorIBA 01/2018
1	Ketamine FDA LinkGeneric 05/2013
1	Antidepressive Agents (Antidepressants)IBA 05/2013
1	Glutamic Acid (Glutamate)FDA Link 05/2013
1	N-Methylaspartate (NMDA)IBA 05/2013
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2013
1	Etoposide (VP 16)FDA LinkGeneric 11/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2012
1	Alkylating AgentsIBA 11/2012
1	TabletsIBA 09/2012
1	Coloring Agents (Dyes)IBA 07/2011
1	AntibodiesIBA 07/2011
1	Minichromosome Maintenance ProteinsIBA 07/2011
1	Ethanol (Ethyl Alcohol)IBA 04/2011
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2006
1	tanespimycin (17AAG)IBA 12/2006
1	geldanamycinIBA 12/2006
1	Proteins (Proteins, Gene)FDA Link 09/2006
1	LipidsIBA 07/2006
1	EmulsionsIBA 07/2006
1	BuffersIBA 07/2006
1	CarbohydratesIBA 11/2005
1	Dietary Fats (Dietary Fat)IBA 05/2005
1	Estrogens (Estrogen)FDA Link 05/2005
1	Oral ContraceptivesIBA 02/2005
1	AcetoneIBA 08/2003
1	Pentylenetetrazole (Metrazol)IBA 08/2003
1	trans- 1,4- Bis(2- chlorobenzaminomethyl)cyclohexane DihydrochlorideIBA 08/2003
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2002
1	Protein Isoforms (Isoforms)IBA 02/2002
1	Macrocyclic LactamsIBA 02/2002
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2002
1	CholesterolIBA 01/2002
1	LDL CholesterolIBA 01/2002
1	IsoflavonesIBA 01/2002

Therapy/Procedure

6	Ketogenic Diet 12/2006 - 08/2003
4	Drug Therapy (Chemotherapy) 05/2013 - 03/2005
2	Therapeutics 01/2021 - 12/2011
1	Lenses 01/2018
1	Retention in Care 05/2015
1	Polypharmacy 05/2013
1	Radiotherapy 11/2012
1	Adjuvant Chemotherapy 11/2012
1	Time-to-Treatment 09/2012
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 09/2006
1	Protein-Restricted Diet (Diet, Protein Restricted) 11/2005
1	Electrodes (Electrode) 03/2003